These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16895964

  • 1. Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism.
    Ayturk S, Gursoy A, Bascil Tutuncu N, Ertugrul DT, Guvener Demirag N.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4260-3. PubMed ID: 16895964
    [Abstract] [Full Text] [Related]

  • 2. Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism.
    Tassone F, Procopio M, Gianotti L, Visconti G, Pia A, Terzolo M, Borretta G.
    Diabet Med; 2009 Oct; 26(10):968-73. PubMed ID: 19900227
    [Abstract] [Full Text] [Related]

  • 3. A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism.
    Gianotti L, Tassone F, Cesario F, Pia A, Razzore P, Magro G, Piovesan A, Borretta G.
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3011-6. PubMed ID: 16735490
    [Abstract] [Full Text] [Related]

  • 4. Relationship between insulin sensitivity and bone mineral density in primary hyperparathyroidism.
    Gianotti L, Tassone F, Baffoni C, Pellegrino M, Cassibba S, Castellano E, Magro G, Cesario F, Visconti G, Borretta G.
    Clin Endocrinol (Oxf); 2014 Sep; 81(3):350-5. PubMed ID: 24750210
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Alendronate increases bone mineral density in patients with symptomatic primary hyperparathyroidism].
    Misiorowski W.
    Endokrynol Pol; 2005 Sep; 56(6):871-5. PubMed ID: 16821204
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism.
    Kaji H, Nomura R, Yamauchi M, Chihara K, Sugimoto T.
    Horm Metab Res; 2006 Jun; 38(6):411-6. PubMed ID: 16823724
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bone metabolism in patients with primary hyperparathyroidism before and after surgery.
    Kerschan-Schindl K, Riss P, Krestan C, Rauner M, Bieglmayer C, Gleiss A, Fialka-Moser V, Niederle B, Pietschmann P.
    Horm Metab Res; 2012 Jun; 44(6):476-81. PubMed ID: 22495973
    [Abstract] [Full Text] [Related]

  • 15. Changes in serum leptin and adiponectin concentrations and insulin resistance after curative parathyroidectomy in moderate to severe primary hyperparathyroidism.
    Bhadada SK, Bhansali A, Shah VN, Rao DS.
    Singapore Med J; 2011 Dec; 52(12):890-3. PubMed ID: 22159932
    [Abstract] [Full Text] [Related]

  • 16. Parathyroid hormone and insulin resistance in distinct phenotypes of severe obesity: a cross-sectional analysis in middle-aged men and premenopausal women.
    Bellia A, Marinoni G, D'Adamo M, Guglielmi V, Lombardo M, Donadel G, Gentileschi P, Lauro D, Federici M, Lauro R, Sbraccia P.
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4724-32. PubMed ID: 23027922
    [Abstract] [Full Text] [Related]

  • 17. Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism.
    Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A, Chihara K.
    J Clin Endocrinol Metab; 2000 May; 85(5):1901-7. PubMed ID: 10843172
    [Abstract] [Full Text] [Related]

  • 18. Primary Hyperparathyroidism: The Influence of Bone Marrow Adipose Tissue on Bone Loss and of Osteocalcin on Insulin Resistance.
    Mendonça ML, Batista SL, Nogueira-Barbosa MH, Salmon CE, Paula FJ.
    Clinics (Sao Paulo); 2016 Aug; 71(8):464-9. PubMed ID: 27626477
    [Abstract] [Full Text] [Related]

  • 19. Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis.
    Sankaran S, Gamble G, Bolland M, Reid IR, Grey A.
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1653-62. PubMed ID: 20130069
    [Abstract] [Full Text] [Related]

  • 20. Low density lipoprotein-cholesterol levels affect vertebral fracture risk in female patients with primary hyperparathyroidism.
    Kaji H, Hisa I, Inoue Y, Sugimoto T.
    Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):371-6. PubMed ID: 19609845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.